It unveils their functions in PAAD and proposes plausible mechanisms by which SP100 members contribute to the initiation and progression of PAAD, utilizing diverse analytical approaches such as gene expression analysis, genetic variation assessment, promoter methylation examination, evaluation of immune cell infiltration, gene enrichment analysis, protein-protein interaction network exploration, and investigation of drug sensitivity. This evidence concerns the gene SP100 and pancreatic adenocarcinoma.